DNA2.0, the leading bioengineering solutions provider, introduced the piggyBac Mammalian Expression System, an efficient, one plasmid method to create stable transfectants in mammalian cells. Licensed from Transposagen Biopharmaceuticals Inc., the piggyBac transposon system includes reversible genetic modification and rapid insertion site characterization. DNA2.0 scientists have taken Transposagen’s best-in-class genetic modification system and optimized it for the company’s all-in-one pHULK vectors. Applications range from stem cell research to protein production and cell line engineering.
“By pairing powerful third-party solutions such as Transposagen’s piggyBac system with our world-class gene design expertise and industry-leading gene synthesis, DNA2.0 can ensure that our customers have the competitive edge,” said Claes Gustafsson, cofounder and Chief Commercial Officer of DNA2.0.
DNA2.0’s piggyBac vectors are the first to come with CometGFP, a green fluorescent protein for easy confirmation of transfection, protein production, or cellular localization. pHULK piggyBac mammalian expression vectors are available as catalog items and for custom cloning for synthetic genes. Like all DNA2.0 products, pHULK vectors are manufactured at the company’s facility in Menlo Park, California. DNA2.0 customers maintain full rights to their intellectual property.
Date: May 24, 2012
Source: DNA2.0
Filed Under: Drug Discovery
